Association of VAMP-2 and syntaxin 1A genes with adult attention deficit hyperactivity disorder

Psychiatry Investigation

Volumn 11, Issue 1, 2014, Pages 76-83

  Kenar, Aye Nur Inci ^a   Ay, Özlem Izci ^b   Herken, Hasan ^c   Erdal, Mehmet Emin ^b  

^a DENIZLI STATE HOSPITAL   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

^c PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

ADHD; Genetic; Synaptobrevin 2; Syntaxin 1A; VAMP 2

Indexed keywords

ADULT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DNA POLYMORPHISM; DOPAMINERGIC SYSTEM; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SYNAPTOBREVIN 2 GENE; SYNTAXIN 1A GENE; YOUNG ADULT;

EID: 84893338563     PISSN: 17383684     EISSN: 19763026     Source Type: Journal    
DOI: 10.4306/pi.2014.11.1.76     Document Type: Article

References (28)

1. Mick E, Faraone SV. Genetics of attention deficit hyper-activity disorder. Child Adolesc Psychiatr Clin N Am 2008;17:261-284.
2. Rutter M, Silberg J. Gene-environment interplay in relation to emotional and behavioral disturbance. Annu Rev Psychol 2002;53:463-490.
3. Zoroǧlu SS, Erdal ME, Alaşehirli B, Erdal N, Sivasli E, Tutkun H et al. Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology 2002;45:176-181.
4. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, et al. Comparison of the role of dopamine, serotonin and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 2000;57:178-196.
5. Wilson MC. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 2000;24:51-57.
6. Kimura K, Mizoguchi A, Ide C. Regulation of growth cone extension by SNARE proteins. J Histochem Cytochem 2003;51:429-433.
7. Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol Psychiatry 2002;7:913-917.
8. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry 2000;5:405-409.
9. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attentiondeficit/hyperactivity disorder. Biol Psychiatry 2005;57:1313-1323.
10. Herken H, Erdal ME, Sengul C, Yucel E, Cakaloz B, Kenar Aİ, et al. Adult attention deficit hyperactivity disorder association with synaptosomal-associated protein (SNAP-25) polymorphisms. Paris, France: 9th World Congress of Biological Psychiatry, June 28-July 2, 2009.
11. Öner Ö, Aki{dotless}n A, Herken H, Erdal ME, Çiftçi K, Ay ME, et al. Association among SNAP-25 Gene DdeI and MnlI polymorphisms and hemodynamic changes during methylphenidate use: a functional nearinfrared spectroscopy study. J Atten Disord 2011;15:628-637.
12. Kawashima K, Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, et al. No association between tagging SNPs of SNARE complex genes (STX1A, VAMP2 and SNAP25) and schizophrenia in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 2008;147B: 1327-1331.
13. Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, Simon N, et al. Clinical and diagnostic implications of lifetime attentiondeficit/ hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry 2005;57:1467-1473.
14. Abou Jamra R, Gobina CM, Becker T, Georgi A, Schulze TG, Schmael C, et al. Association study between genetic variants at the VAMP2 and VAMP3 loci and bipolar affective disorder. Psychiatr Genet 2008;18: 199-203.
15. Wong AH, Trakalo J, Likhodi O, Yusuf M, Macedo A, Azevedo MH, et al. Association between schizophrenia and the syntaxin 1A gene. Biol Psychiatry 2004;56:24-29.
16. Gabriel SM, Haroutunian V, Powchik P, Honer WG, Davidson M, Davies P, et al. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Arch Gen Psychiatry 1997; 54:559-566.
17. Sokolov BP, Tcherepanov AA, Haroutunian V, Davis KL. Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients. Biol Psychiatry 2000;48:184-196.
18. Bartl J, Link P, Schlosser C, Gerlach M, Schmitt A, Walitza S, et al. Effects of methylphenidate: the cellular point of view. Atten Defic Hyperact Disord 2010; 2:225-232.
19. McCann BS, Schele L, Ward N, Roy-Byrne P. Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 2000;12:240-245.
20. Oncü B, Olmez S, Sentürk V. Validity and reliability of the Turkish version of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. Turk Psikiyatr Derg 2005;16:252-259.
21. Günay Ş, Savran C, Aksoy UM, Maner F, Turgay A, Yargi{dotless}ç İ. The Norm Study, Transliteral Equivalence, Validity, Reliability of Adult Hyperactivity Scale in Turkish Adult Population. Türkiyéde Psikiyatri 2006;8:98-107.
22. Ozkurkcugil A, Aydemir O, Yi{dotless}ldi{dotless}z M, Esen Danaci{dotless} A, Köroǧlu E. Turkish version and reliability of Structured Clinical Interview For DSM-IV Axis I Disorders. Ilac ve Tedavi Dergisi 1999;12:233-236.
23. Sorias S, Saygi{dotless}li{dotless} R, Elbi H, Vahip S, Mete L, Nifi{dotless}rne Z, et al. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID II) (Turkish version). İzmir: Ege Universitesi; 1990.
24. Mill J, Curran S, Kent L, Gould A, Huckett L, Richards S, et al. Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. Am J Med Genet 2002;114:269-271.
25. Li Q, Wong JH, Lu G, Antonio GE, Yeung DK, Nq TB, et al. Gene expression of synaptosomal-associated protein 25 (SNAP-25) in the prefrontal cortex of the spontaneously hypertensive rat (SHR). Biochim Biophys Acta 2009;1792:766-776.
26. Saito S, Takahashi N, Ishihara R, Ikeda M, Suzuki T, Kitajima T, et al. Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients. Neuropsychobiology 2006; 54:226-230.
27. Gökdoǧan TE. Investigation of the relationship between the polymorphisms of the genes encoding presynaptic proteins and Alzheimer's disease. Candidate's thesis study. Mersin: Department of Medical Biology and Genetics, School of Medicine, Mersin University; 2009.
28. Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Foq JU, et al. Syntaxin 1A Interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol Pharmacol 2008;74:1101-1108